FDA Inspection 1286320 — Mayo Clinic Rochester, Division of Transfusion Medicine

Mayo Clinic Rochester, Division of Transfusion Medicine — FEI 2172560

The FDA completed an inspection of Mayo Clinic Rochester, Division of Transfusion Medicine on September 17, 2025 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 17, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Rochester, MN (United States)